Genetic linkage analysis of head and neck cancer in a Spanish family

Objectives To describe the genetic variants that may be associated with the development of head and neck cancer (HNC) and functionally validating the molecular implications. Materials and Methods A prospective observational study was carried out on a family of 3 generations in which 3 members had de...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oral diseases 2024-04, Vol.30 (3), p.1032-1039
Hauptverfasser: Pérez‐Sayáns, Mario, Chamorro‐Petronacci, Cintia M., Bravo, Susana B., Padín‐Iruegas, María E., Guitián‐Fernández, Esteban, Barros‐Angueira, Francisco, Quintas‐Rey, Rita, García‐García, Abel
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objectives To describe the genetic variants that may be associated with the development of head and neck cancer (HNC) and functionally validating the molecular implications. Materials and Methods A prospective observational study was carried out on a family of 3 generations in which 3 members had developed HNC. Peripheral blood sample was taken in a routine procedure for exome sequencing in one relative and genotyping in the remaining twelve relatives. For the functional analysis all‐trans retinoic acid (atRA) was extracted from saliva and serum and measured using ultra‐performance liquid chromatography–tandem mass spectrometry (UPLC‐MS/MS). The presence of HPV‐DNA. Results None of the patients smoked or consumed alcohol. The presence of HPV DNA was not detected in any of the biopsied samples. A total amount of 6 members out of 13 (46.15%) carried out the same mutation of CYP26B1 (2p13.2; G>T). The mean plasma concentration of atRA was 3.3109 ± 1.4791 pg/mL for the study family and 4.7370 ± 1.5992 pg/mL for the controls (p = 0.042). Conclusion Lower levels of atRA were confirmed in the study family, which may open the way to the possible relationship between the polymorphism CYP26B1 (2p13.2; G>T) and HNC.
ISSN:1354-523X
1601-0825
1601-0825
DOI:10.1111/odi.14572